配合化学療法の市場規模、シェア、成長分析：製品タイプ別、配合タイプ別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

配合化学療法の世界市場規模は2023年に57億8,000万米ドルとなり、予測期間（2025-2032年）のCAGRは6.4%で、2024年の61億5,000万米ドルから2032年には101億米ドルに成長する見通しです。

世界の配合化学療法市場は、主にがん罹患率の上昇と医薬品配合技術の進歩によって力強い成長を遂げています。がんに罹患しやすい高齢者層の増加は、個別化治療ソリューションの必要性を強調しています。しかし、同市場は、厳しい規制の枠組みや調剤業務に関する安全性の懸念といった課題に直面しており、コンプライアンスと患者の安全性の重要性が浮き彫りになっています。一方で、革新的な配合技術の開発や精密医療の普及など、新たなビジネスチャンスも生まれており、これらは市場をさらに活性化させると思われます。全体として、この情勢は配合化学療法の将来を形作る課題と進歩の融合を示しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢

配合化学療法市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 経口
• 注射可能
• 局所

配合化学療法市場規模：配合タイプ別& CAGR（2025-2032）

• 市場概要
• 滅菌済み
• 非滅菌

配合化学療法市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 腫瘍学
• 血液学
• その他

配合化学療法市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 専門クリニック
• 在宅ケア環境
• その他

配合化学療法市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• B. Braun Melsungen AG（Germany）
• Fagron NV（Netherlands）
• Baxter International Inc.（USA）
• Fresenius Kabi AG（Germany）
• BioScrip, Inc.（USA）
• Advanced Pharma, Inc.（USA）
• PharMEDium Services, LLC（USA）
• QuVa Pharma, Inc.（USA）
• Nephron Pharmaceuticals Corporation（USA）
• Central Admixture Pharmacy Services, Inc.（USA）
• McGuff Compounding Pharmacy Services, Inc.（USA）
• Cantrell Drug Company（USA）
• Triangle Compounding Pharmacy（USA）
• Wedgewood Pharmacy（USA）
• Pencol Compounding Pharmacy（USA）
• Smiths Medical（USA）
• ICU Medical, Inc.（USA）
• Option Care Health, Inc.（USA）
• Pharmedium Services, LLC（USA）

結論と提言

Global Compounding Chemotherapy Market size was valued at USD 5.78 billion in 2023 and is poised to grow from USD 6.15 billion in 2024 to USD 10.1 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

The global compounding chemotherapy market is experiencing robust growth, primarily driven by rising cancer incidence and advancements in pharmaceutical compounding technologies. The growing elderly demographic, which is more prone to cancer, underscores the necessity for personalized treatment solutions. However, the market contends with challenges such as stringent regulatory frameworks and safety concerns related to compounding practices, highlighting the critical importance of compliance and patient safety. On a positive note, emerging opportunities abound, including the development of innovative compounding technologies and the rising adoption of precision medicine, which are set to propel the market further. Overall, the landscape illustrates a blend of challenges and advancements that shape the future of compounding chemotherapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Compounding Chemotherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Compounding Chemotherapy Market Segments Analysis

Global Compounding Chemotherapy Market is segmented by Product Type, Compounding Type, Application, End User and region. Based on Product Type, the market is segmented into Oral, Injectable and Topical. Based on Compounding Type, the market is segmented into Sterile and Non-Sterile. Based on Application, the market is segmented into Oncology, Hematology and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics, Homecare Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Compounding Chemotherapy Market

The global compounding chemotherapy market is experiencing significant growth driven by the shift towards personalized medicine. As healthcare providers increasingly recognize the importance of individualized treatment plans, there is a heightened demand for customized chemotherapy solutions. Compounding chemotherapy is well-positioned to take advantage of this trend by providing therapies tailored to meet specific patient needs. This includes taking into account unique factors such as genetic profiles, disease characteristics, and individual responses to treatments. By enabling the formulation of bespoke medications, compounding chemotherapy aligns with the evolving healthcare landscape, where personalized approaches are deemed crucial to enhancing treatment efficacy and improving patient outcomes.

Restraints in the Global Compounding Chemotherapy Market

A significant obstacle facing the global compounding chemotherapy market is the lack of standardized practices and formulations. This inconsistency in compounding methodologies raises serious concerns regarding the dependability and effectiveness of compounded chemotherapy medications. Variations in drug formulation, stability, and potency can lead to fluctuations in treatment outcomes for patients, undermining the overall therapeutic effectiveness. Furthermore, the absence of uniform protocols complicates the ability of healthcare providers to assess and compare various compounded formulations, creating additional challenges in ensuring optimal patient care. This variability not only impacts patient safety but also hinders the overall advancement of the compounding chemotherapy sector.

Market Trends of the Global Compounding Chemotherapy Market

The Global Compounding Chemotherapy market is experiencing a transformative trend driven by advances in pharmacogenomics. As healthcare providers increasingly recognize the importance of individualized treatment, the integration of genetic profiling into compounding chemotherapy is becoming paramount. This trend allows for medications to be specifically tailored to a patient's unique genetic makeup, enhancing treatment efficacy and reducing the likelihood of adverse reactions. As a result, the demand for personalized compounding services is rising, propelling market growth. Additionally, increased collaboration among oncologists, pharmacists, and geneticists further supports the expansion of this market, positioning it for significant developments in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Compounding Chemotherapy Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Oral
• Injectable
• Topical

Global Compounding Chemotherapy Market Size by Compounding Type & CAGR (2025-2032)

• Market Overview
• Sterile
• Non-Sterile

Global Compounding Chemotherapy Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
• Hematology
• Others

Global Compounding Chemotherapy Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Homecare Settings
• Others

Global Compounding Chemotherapy Market Size & CAGR (2025-2032)

• North America (Product Type, Compounding Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Compounding Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Compounding Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Compounding Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Compounding Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fagron NV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioScrip, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Pharma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharMEDium Services, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuVa Pharma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nephron Pharmaceuticals Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Central Admixture Pharmacy Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McGuff Compounding Pharmacy Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cantrell Drug Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Triangle Compounding Pharmacy (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wedgewood Pharmacy (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pencol Compounding Pharmacy (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Option Care Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmedium Services, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations